LRPA
LHDX

L. Roy Papp & Associates’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

L. Roy Papp & Associates’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-150,699
Closed -$16.7K – 170
2022
Q4 		$16.7K Buy
150,699
+36,205
+32% +$23.1K ﹤0.01% 166
2022
Q3 		$121K Sell
114,494
-10,000
-8% -$22.8K 0.02% 161
2022
Q2 		$232K Buy
124,494
+16,489
+15% +$40.1K 0.03% 158
2022
Q1 		$386K Buy
108,005
+62,505
+137% +$307K 0.05% 140
2021
Q4 		$392K Sell
45,500
-350
-0.8% -$2.23K 0.04% 146
2021
Q3 		$348K Buy
+45,850
New +$387K 0.04% 149
2021
Q2 		– Sell
-45,350
Closed -$549K – 177
2021
Q1 		$549K Buy
+45,350
New +$900K 0.08% 118

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $3.23B AUM 62.07% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return